Impact of short-duration lifestyle intervention in collaboration with general practitioners in patients with the metabolic syndrome

Bihan, H.; Takbou, K.; Cohen, R.; Michault, Alain; Boitou, F.; Réach, G.; Clésiau, H. Le

doi:10.1016/j.diabet.2008.11.002

Cited by 25 publications

(17 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Our higher remission rate might be explained by the intensity of our usual care, which was presumably higher than control group care as described by Orchard et al and Bo et al In these studies participants received lifestyle recommendations once, while the majority of our participants was seen several times by the practice nurse. The remission rate of 52 % observed in a prospective study more closely resembled our remission rate, which could be explained by an intervention more in agreement with our usual care [28]. However the follow-up period was only six months; it is uncertain what would have happened after this relatively short intervention period.…”

Section: Discussionsupporting

confidence: 79%

Remission of screen-detected metabolic syndrome and its determinants: an observational study

et al. 2012

View full text Add to dashboard Cite

BackgroundEarly detection and treatment of the metabolic syndrome may prevent diabetes and cardiovascular disease. Our aim was to assess remission of the metabolic syndrome and its determinants after a population based screening without predefined intervention in the Netherlands.MethodsIn 2006 we detected 406 metabolic syndrome cases (The National Cholesterol Education Program’s Adult Treatment Panel III (NCEP ATP III) definition) among apparently healthy individuals with an increased waist circumference. They received usual care in a primary care setting. After three years metabolic syndrome status was re-measured. We evaluated which baseline determinants were independently associated with remission.ResultsThe remission rate among the 194 participants was 53%. Baseline determinants independently associated with a remission were the presence of more than three metabolic syndrome components (OR 0.46) and higher levels of waist circumference (OR 0.91), blood pressure (OR 0.98) and fasting glucose (OR 0.60).ConclusionsIn a population with screen-detected metabolic syndrome receiving usual care, more than half of the participants achieved a remission after three years. This positive result after a relatively simple strategy provides a solid basis for a nation-wide implementation. Not so much socio-demographic variables but a higher number and level of the metabolic syndrome components were predictors of a lower chance of remission. In such cases, primary care physicians should be extra alert.

show abstract

Section: Discussionsupporting

confidence: 79%

Remission of screen-detected metabolic syndrome and its determinants: an observational study

et al. 2012

View full text Add to dashboard Cite

show abstract

“…Adverse outcomes of exercise regimes such as tiredness, musculoskeletal issues, or social embarrassment should be addressed with empathy to improve patients' weight-related attitudes [147]. Patients should be regularly followed up to assess their progress as well as to address any of their queries [148]. Frequent telephone contact with a dietician was found to be as effective as face-to-face dietician contact for supporting lifestyle modification in obese patients trying to lose weight [149].…”

Section: Factors Affecting Compliance With Lifestyle Changesmentioning

confidence: 99%

Evidence of Lifestyle Modification in the Management of Hypercholesterolemia

Mannu

Zaman²,

Gupta³

et al. 2013

Current Cardiology Reviews

View full text Add to dashboard Cite

Background:Coronary heart disease (CHD) is the leading cause of morbidity and mortality worldwide. The growth of ageing populations in developing countries with progressively urbanized lifestyles are major contributors. The key risk factors for CHD such as hypercholesterolemia, diabetes mellitus, and obesity are likely to increase in the future. These risk factors are modifiable through lifestyle. Objectives: To review current literature on the potential benefit of cholesterol lowering in CHD risk reduction with a particular focus on the evidence of non-pharmacological/lifestyle management of hypercholesterolemia. Methods:Medline/PubMed systematic search was conducted using a two-tier approach limited to all recent English language papers. Primary search was conducted using key words and phrases and all abstracts were subsequently screened and relevant papers were selected. The next tier of searching was conducted by (1) reviewing the citation lists of the selected papers and (2) by using PubMed weblink for related papers. Over 3600 reports were reviewed.Results:Target cholesterol levels set out in various guidelines could be achieved by lifestyle changes, including diet, weight reduction, and increased physical activity with the goal of reducing total cholesterol to <200 mg/dL and LDL-C <100mg/dL. Various dietary constituents such as green tea, plant sterols, soy protein have important influences on total cholesterol. Medical intervention should be reserved for those patients who have not reached this goal after 3 months of non-pharmacological approach. Conclusion:CHD remains as a leading cause of death worldwide and hypercholesterolemia is an important cause of CHD. Non-pharmacological methods provide initial as well as long-term measures to address this issue.

show abstract

“…Dans notre étude, l'obésité a touché 56,6 % des cas. L'étude de Bihan H et al [10] ont rapporté des résultats comparables aux nôtres : 61 % des sujets étaient obèses, l'IMC moyen était de 31,5 ± 5 cm/m 2 et le tour de taille moyen était de 103 ± 11,5 cm. L'enquête PRESYMAG [11] faite sur une population tunisienne et algérienne a aussi rapporté des résultats similaires.…”

Section: Discussionunclassified

Relation entre l’homocystéine et la créatinine sanguines chez des sujets atteints de syndrome métabolique et association entre l’hyperhomocystéinémie et le syndrome métabolique

Ferjani

Bouzid

Khiari

et al. 2011

Immuno-analyse & Biologie Spécialisée

View full text Add to dashboard Cite

Impact of short-duration lifestyle intervention in collaboration with general practitioners in patients with the metabolic syndrome

Cited by 25 publications

References 22 publications

Remission of screen-detected metabolic syndrome and its determinants: an observational study

Remission of screen-detected metabolic syndrome and its determinants: an observational study

Evidence of Lifestyle Modification in the Management of Hypercholesterolemia

Relation entre l’homocystéine et la créatinine sanguines chez des sujets atteints de syndrome métabolique et association entre l’hyperhomocystéinémie et le syndrome métabolique

Contact Info

Product

Resources

About